GREG YAP CHIEF EXECUTIVE OFFICER AND CO-FOUNDER
Greg is an entrepreneurial leader and general manager who specializes in building growing companies in life science technologies, translational medicine, and medical diagnostics. Greg was most recently the first healthcare Entrepreneur in Residence at GE, where he led strategic assessment for novel GE technology. Previously, Greg was Lifecycle Leader, Advanced Staining Assays, at Ventana / Roche Diagnostics, with responsibility for its market-leading ~$500M cancer diagnostic assay business, whose products help guide treatment for nearly half of cancer patients worldwide. Greg was Chief Operating Officer of CELLective Dx (circulating tumor cells) and held multiple general management roles at Affymetrix (microarrays) including VP Molecular Diagnostics and VP DNA Products. Greg has worked in venture capital with Bay City Capital and in management consulting with McKinsey & Company. He is a board director of Outward Bound California and Outward Bound Services Group. Greg received his MBA from Stanford University and his AB in molecular biology, summa cum laude, from Princeton University.